In a filing, Sonoma Pharmaceuticals Inc revealed its 10% Owner Gottfurcht Grant acquired Company’s shares for reported $0.23 million on Jan 03 ’25. In the deal valued at $2.70 per share,86,111 shares were bought.
Then, Gottfurcht Grant bought 30,000 shares, generating $80,684 in total proceeds.
Before that, Gottfurcht Grant bought 17,806 shares. Sonoma Pharmaceuticals Inc shares valued at $48,562 were divested by the Open Market Purchase at a price of $2.73 per share.
Price Performance Review of SNOA
On Friday, Sonoma Pharmaceuticals Inc [NASDAQ:SNOA] saw its stock jump 9.59% to $4.23. Over the last five days, the stock has gained 83.91%. Sonoma Pharmaceuticals Inc shares have risen nearly 57.25% since the year began. Nevertheless, the stocks have risen 33.02% over the past one year. While a 52-week high of $9.37 was reached on 03/11/25, a 52-week low of $1.75 was recorded on 04/07/25. SMA at 50 days reached $2.66, while 200 days put it at $3.40.
Levels Of Support And Resistance For SNOA Stock
The 24-hour chart illustrates a support level at 3.82, which if violated will result in even more drops to 3.41. On the upside, there is a resistance level at 4.47. A further resistance level may holdings at 4.71. The Relative Strength Index (RSI) on the 14-day chart is 72.31, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.40, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 2.75%. Stochastics %K at 91.06% indicates the stock is a selling.
How much short interest is there in Sonoma Pharmaceuticals Inc?
A steep rise in short interest was recorded in Sonoma Pharmaceuticals Inc stocks on 2025-04-15, dropping by -0.17 million shares to a total of 52654.0 shares. Yahoo Finance data shows the prior-month short interest on 2025-03-14 was 0.23 million shares. There was a decline of -329.0%, which implies that there is a negative sentiment for the stock.
